14 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
Fingertip Pulse Oximeter
FDA 510(k)
FDA Class 2
·Cardiovascular
ZenFlex
FDA UDI
Kerr Corporation·00195062029769·Rotary Files
Origin Lateral Offset Collared Hip Stem
FDA UDI
SIGNATURE ORTHOPAEDICS PTY LTD·09348215017811·
Origin Hip Stem
FDA UDI
SIGNATURE ORTHOPAEDICS PTY LTD·09348215051808·
PYRENEES Cervical Plate System
FDA UDI
VB Spine LLC·10888857298880·Stop Drill, Size Dia. 2.5x14 mm
Paxeon Origin
FDA UDI
PAXEON RECONSTRUCTION LLC·08177570205035·
AED MONOPOLAR LAP ACCESSORIES
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
DUSIMETRY CHECK
FDA 510(k)
FDA Class 2
·Radiology
STRATUS Stem - High Offset - Collared - Size 15
FDA UDI
AMPLITUDE SAS·03701089504959·
ECHELON*FLEX60 LONG
FDA Adverse Event
Malfunction
·ETHICON ENDO-SURGERY, LLC.·Product code GDW·June 21, 2013
DUROM ACETABULAR COMPONENT
FDA Adverse Event
Other
·ZIMMER GMBH·Product code KWA·July 8, 2011
DURA STAR RX PTCA BALLOON CATHETER
FDA Adverse Event
Malfunction
·CORDIS DE MEXICO·Product code LOX·September 25, 2008
INNOVA IGS 530
FDA Adverse Event
Injury
·GE MEDICAL SYSTEMS SCS·Product code OWB·August 2, 2019
Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014